I haven't added to ICN today - probably will not do so unless it breaks $9. It is disappointing that all these companies are doubling by issuing PR's that they are working on SARS (it could be years, if ever, before one of them are successful) while the only drug that the World Health Organization says has been effective in the treatment of the disease (ICN's ribavirin) has been ignored. I think ICN could use a little PR at the moment to help get the word out.